# Psychoactive substance disorder: first experience In a comprehensive model of harm reduction model in Bogotá Colombia, 2017-2021

**Authors:** A. S. Quesada, M. Cote

PMC · DOI: 10.1192/j.eurpsy.2024.818 · 2024-08-27

## TL;DR

This paper shares the experience of implementing an outpatient harm reduction program for psychoactive substance disorder in Bogotá, Colombia, from 2017 to 2021.

## Contribution

The study presents a novel outpatient harm reduction model adapted for a Latin American health system.

## Key findings

- The majority of patients were men aged 29-59 years.
- Up to 30% of patients achieved controlled consumption or total suspension without inpatient care.
- Patients showed motivation and adherence to the outpatient program.

## Abstract

In Colombia the traditional treatment model implies the needing of a total cessation of consume to be able to acces an impatientand long stance rehabilitation program. However, literature in other countries expériences had sugested and used a harm reduction program with an otpatien rehabilitation program.

As this programs are more cost-effective and enables the patient to continue his daily life, perpetuate his life style, keep and enhance the psychosocial network, an outpatient comprehensive multimodular program was designed to adapt to a health promotion company (EPS for its spanish acronym) and has been used since 2017.

share the expérience aquired in an undeveloped country of latin AmericaThe tipification in the main substance consumption in the development group as well as it’s differentiation in gender and age group

share the expérience aquired in an undeveloped country of latin America

The tipification in the main substance consumption in the development group as well as it’s differentiation in gender and age group

Expérience and results

The majority of patients are men over womenthe predominant age group is between 29-59 years oldthere is a difference between the age group depending on the substance of impact

The majority of patients are men over women

the predominant age group is between 29-59 years old

there is a difference between the age group depending on the substance of impact

The experience have shown that up to 30% of the population treated have gotten to a controlled consumption or the total suspension without the needing of an impatient program In général thé patient have shown motivation and adherence to an outpatient program

None Declared

---
Source: https://tomesphere.com/paper/PMC11859683